Allarity Therapeutics, Inc. Convertible Debt
Allarity Therapeutics, Inc. (ALLR) had Convertible Debt of $889.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2024-03-08
- 2018-11-29: Convertible Debt 200.00M SEK.
SEK
| Period end | Convertible Debt |
|---|---|
| 2018-11-29 | 200.00M SEK 10-Q/A · filed 2022-05-17 |
USD
| Period end | Convertible Debt |
|---|---|
| 2023-12-31 | $889.00K 10-K · filed 2024-03-08 |
| 2023-09-30 | $876.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $863.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $850.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $838.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $825.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $812.00K 10-Q · filed 2022-10-07 |
| 2022-03-31 | $798.00K 10-Q · filed 2022-05-27 |
| 2021-12-31 | $785.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | $773.00K 10-Q/A · filed 2022-05-17 |
| 2020-12-31 | $737.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |